Wistar Wire: Funding

wistar
Yesterday, Dario Altieri, M.D., our director of The Wistar Institute Cancer Center, Executive Vice President, and Chief Scientific Officer, presented testimony in Harrisburg before the Senate Majority Policy Committee to advocate for preserving CURE funding.
Funding
wistar
In his budget for fiscal year 2013, Governor Tom Corbett proposes to de-fund the CURE program created by Act 77, the Tobacco Settlement Fund legislation, in 2001. Hospitals and research institutes across the state stand to lose a combined $60 million in research funding; Wistar itself has about $1.5 million a year at stake. The proposed de-funding will have a significant impact on Wistar.
Funding
wistar
Last month, we shared the news of the need for increased NIH funding for 2013. The petition to bring this issue before the White House needed 25,000 signatures by March 18, and fell short by a mere 446 signatures. But hope is not lost!
Funding
wistar
NIH budget cuts mean that a potential cancer treatment could go untested, or that researchers might not be able to explore new avenues of research. It means a loss of jobs and impairs our ability to train young scientists. One of our colleagues in the research community has posted a petition on the official White House website. This petition must get 25,000 signatures by March 18 if the White House is to review it.
Funding